Robert Lenz is leaving the brain drug developer to “pursue other interests.” Elsewhere, Atara is cutting half of its staff ...

Novartis has added another non-alcoholic steatohepatitis (NASH) drug candidate to its pipeline via an $80 million licensing deal with US biotech Pliant ... with obesity, diabetes and high ...

Ed Kaye, Stoke’s longtime leader, will be replaced by former Vertex executive Ian Smith. Elsewhere, all 12 drugmakers ...

SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that its Board of Directors has unanimously adopted a limited duration ...

Pliant Therapeutics has terminated a Phase IIb of bexotegrast in idiopathic pulmonary fibrosis (IPF) over safety concerns, further spiralling the company’s stock. The US-based company has ...

TD Cowen analyst Ritu Baral maintained a Buy rating on Pliant Therapeutics (PLRX – Research Report) today. The company’s shares closed last Friday at $3.04. See what stocks are receiving ...

Following a prespecified data review and recommendation by the trial’s independent DSMB, as well as a secondary review and recommendation by an outside expert panel, Pliant has discontinued the ...

New Tech for Managing Type 1 Diabetes Is Effective for Older Adults Mar. 11, 2025 — New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older ...

A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research from the University of East Anglia. Many cancer patients go on to ...

WASHINGTON – The Oval Office meeting convened by President Donald Trump brought together the most important leaders in the world of professional golf: Jay Monahan, the top executive at the PGA ...

Norms recognized for decades in Washington by both parties no longer appear to apply to the Trump White House, former prosecutors and ethics lawyers say. By Eric Lipton and Maggie Haberman ...

appointing pliant candidates, and later doling out political appointments to incumbents as a reward for their services after stepping down". The BJP leader also shared a list of several former ...